|Edwards Lifesciences Corporation -- USA Stock|| |
USD 134.25 0.07 0.0521%
Chairman and CEO
Mr. Michael A. Mussallem is Chairman of the Board, Chief Executive Officer of the Company. He has an extensive knowledge of the medical technology industry in general, and of the people, operations, processes and products of the Company, in particular, built over a 35year career with the Company and its predecessor. In addition, in his roles with AdvaMed and other healthcarerelated organizations, he has become a recognized leader in the medical technology industry, making important contributions to healthcare policy discussions in California, the United States and the key global markets that the Company serves. These experiences have established relationships which are helpful in developing the Board strategic perspective and enhanced his leadership of the Company and contributions to the Board. He received his BS in Chemical Engineering and an honorary doctoral degree from the Rose Hulman Institute of Technology
Age: 63 Chairman Since 2000 Ph.D
Michael Mussallem Latest Insider Activity
The company has Return on Asset (ROA)
of 12.53 %
which means that for every $100 of asset it generated profit of $12.53. This is typical in the industry. Likewise, it shows return on total equity (ROE)
of 20.94 %
which means that it produced $20.94 on every 100 dollars invested by current stockholders.
The company reports 1.04 B of total liabilities with total debt to equity ratio (D/E) of 35.0 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 1.76 which is generally considered normal.
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Appliances Equipment classification in USA and traded on New York Stock Exchange exchange.Edwards Lifesciences Corporation (EW) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 9,800 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.